Oxford BioDynamics Plc
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor i… Read more
Market Cap & Net Worth: Oxford BioDynamics Plc (OXBOF)
Oxford BioDynamics Plc (PINK:OXBOF) has a market capitalization of $17.16 Million ($17.16 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #27623 globally and #9242 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oxford BioDynamics Plc's stock price $0.00 by its total outstanding shares 4290910967 (4.29 Billion).
Oxford BioDynamics Plc Market Cap History: 2020 to 2025
Oxford BioDynamics Plc's market capitalization history from 2020 to 2025. Data shows change from $4.87 Billion to $17.16 Million (-73.46% CAGR).
Oxford BioDynamics Plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oxford BioDynamics Plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
15.67x
Oxford BioDynamics Plc's market cap is 15.67 times its annual revenue
0.69x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $4.87 Billion | $456.00K | -$4.31 Million | 10690.58x | N/A |
| 2021 | $1.93 Billion | $341.00K | -$6.68 Million | 5662.49x | N/A |
| 2022 | $844.88 Million | $154.00K | -$6.71 Million | 5486.24x | N/A |
| 2023 | $1.07 Billion | $510.00K | -$10.83 Million | 2103.39x | N/A |
| 2024 | $90.11 Million | $636.00K | -$11.57 Million | 141.68x | N/A |
| 2025 | $17.16 Million | $1.09 Million | -$14.99 Million | 15.67x | N/A |
Competitor Companies of OXBOF by Market Capitalization
Companies near Oxford BioDynamics Plc in the global market cap rankings as of March 18, 2026.
Key companies related to Oxford BioDynamics Plc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Oxford BioDynamics Plc Historical Marketcap From 2020 to 2025
Between 2020 and today, Oxford BioDynamics Plc's market cap moved from $4.87 Billion to $ 17.16 Million, with a yearly change of -73.46%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $17.16 Million | -80.95% |
| 2024 | $90.11 Million | -91.60% |
| 2023 | $1.07 Billion | +26.97% |
| 2022 | $844.88 Million | -56.24% |
| 2021 | $1.93 Billion | -60.39% |
| 2020 | $4.87 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Oxford BioDynamics Plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.16 Million USD |
| MoneyControl | $17.16 Million USD |
| MarketWatch | $17.16 Million USD |
| marketcap.company | $17.16 Million USD |
| Reuters | $17.16 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.